EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Time-trend analysis of 78 orbicularis oculi myocutaneous flaps in periorbital reconstruction: a single-center retrospective study in South Korea

Yong Chan Bae, Yong Woo Lee, Chi Hyun Lee, Hoon-Soo Kim

Archives of Craniofacial Surgery · 20.10.2025 · 26 (5) · 190-196

DOI: 10.7181/acfs.2025.0028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Craniofacial Surgery, erschienen am 20.10.2025. Verfasst von Yong Chan Bae und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Reconstructive Surgery, Pusan National University School of Medicine, Yangsan, Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Pusan National University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The orbicularis oculi myocutaneous (OOMC) flap offers an excellent match in color, thickness, and texture for periorbital defects, yet large-scale, long-term data remain scarce. To determine whether indications, flap‑design preferences, and complication profiles change as surgical experience accumulates, cases were stratified into an early practice phase (2001–2017) and a contemporary phase following technique refinement and wider adoption (2018–2024).

Methods

All periorbital reconstructions utilizing OOMC flaps between November 2001 and December 2024 were retrospectively reviewed. Cases were stratified into Group A (2001–2017) and Group B (2018–2024). We analyzed patient age, sex, etiology, defect site/number, flap design (V-Y advancement, unipedicle/bipedicle switch, pivot), adjunctive procedures, and complications.

Results

Seventy-eight OOMC flaps were performed in 57 patients for 70 defects. Group A included 25 patients, 30 defects, and 36 flaps, while Group B included 32 patients, 40 defects, and 42 flaps. Basal cell carcinoma was the leading etiology in both periods (77%). The proportion of V-Y advancement flaps rose from 50% (18/36) in Group A to 83% (35/42) in Group B. No flap necrosis occurred, and tumor recurrence was observed only once in Group A.

Conclusion

Despite the relatively short observation window for Group B, OOMC flap use increased markedly, confirming that accumulated surgical experience promotes even more frequent application in periorbital reconstruction. The V-Y advancement variant, in particular, expanded in indication without added morbidity and appears highly reliable for a broad spectrum of periorbital defects.

Schlagwörter

Stichwörter der Autor:innen

Basal cell carcinomaEyelidsMyocutaneous flapSurgical flapsTime factors

Autor:innen und Institutionen

  • Department of Plastic and Reconstructive Surgery, Pusan National University School of Medicine, Yangsan, Korea.
  • Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
  • Department of Dermatology, Pusan National University School of Medicine, Yangsan, Korea.

Förderung

  • Pusan National University

Zitieren

APA

Bae, Y. C., Lee, Y. W., Lee, C. H., & Kim, H. S. (2025). Time-trend analysis of 78 orbicularis oculi myocutaneous flaps in periorbital reconstruction: a single-center retrospective study in South Korea. Archives of Craniofacial Surgery, 26(5), 190-196. https://doi.org/10.7181/acfs.2025.0028

Vancouver

Bae YC, Lee YW, Lee CH, Kim HS. Time-trend analysis of 78 orbicularis oculi myocutaneous flaps in periorbital reconstruction: a single-center retrospective study in South Korea. Archives of Craniofacial Surgery. 2025;26(5):190-196. doi:10.7181/acfs.2025.0028

BibTeX
@article{Bae2025,
  author = {Bae, Yong Chan and Lee, Yong Woo and Lee, Chi Hyun and Kim, Hoon-Soo},
  title = {Time-trend analysis of 78 orbicularis oculi myocutaneous flaps in periorbital reconstruction: a single-center retrospective study in South Korea},
  journal = {Archives of Craniofacial Surgery},
  year = {2025},
  volume = {26},
  number = {5},
  pages = {190--196},
  doi = {10.7181/acfs.2025.0028}
}
Kostenlos starten →